{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T16:21:48Z","timestamp":1792858908241,"version":"4.5.0"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2024,6,5]],"date-time":"2024-06-05T00:00:00Z","timestamp":1717545600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,6,5]],"date-time":"2024-06-05T00:00:00Z","timestamp":1717545600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100008005","name":"Yonsei University College of Medicine","doi-asserted-by":"publisher","award":["2022-32-0057"],"award-info":[{"award-number":["2022-32-0057"]}],"id":[{"id":"10.13039\/501100008005","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003710","name":"Korea Health Industry Development Institute","doi-asserted-by":"publisher","award":["RS-2023-0026536"],"award-info":[{"award-number":["RS-2023-0026536"]}],"id":[{"id":"10.13039\/501100003710","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurol"],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.1007\/s00415-024-12477-z","type":"journal-article","created":{"date-parts":[[2024,6,5]],"date-time":"2024-06-05T19:01:51Z","timestamp":1717614111000},"page":"5213-5222","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Predictors associated with the rate of progression of nigrostriatal degeneration in Parkinson\u2019s disease"],"prefix":"10.1007","volume":"271","author":[{"given":"Han Soo","family":"Yoo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Han-Kyeol","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hye Sun","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"So Hoon","family":"Yoon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Han Kyu","family":"Na","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sung Woo","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jae-Hoon","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Young Hoon","family":"Ryu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2231-672X","authenticated-orcid":false,"given":"Chul Hyoung","family":"Lyoo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,6,5]]},"reference":[{"key":"12477_CR1","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1007\/s00702-017-1692-0","volume":"124","author":"L Klingelhoefer","year":"2017","unstructured":"Klingelhoefer L, Reichmann H (2017) Parkinson\u2019s disease as a multisystem disorder. J Neural Transm (Vienna) 124:709\u2013713","journal-title":"J Neural Transm (Vienna)"},{"key":"12477_CR2","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1093\/brain\/awx118","volume":"140","author":"S-M Fereshtehnejad","year":"2017","unstructured":"Fereshtehnejad S-M, Zeighami Y, Dagher A, Postuma RB (2017) Clinical criteria for subtyping Parkinson\u2019s disease: biomarkers and longitudinal progression. Brain 140:1959\u20131976","journal-title":"Brain"},{"key":"12477_CR3","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1002\/mds.21956","volume":"23","author":"MA Hely","year":"2008","unstructured":"Hely MA, Reid WGJ, Adena MA, Halliday GM, Morris JGL (2008) The Sydney multicenter study of Parkinson\u2019s disease: the inevitability of dementia at 20 years. Mov Disord 23:837\u2013844","journal-title":"Mov Disord"},{"key":"12477_CR4","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1002\/mdc3.12553","volume":"5","author":"SK Holden","year":"2018","unstructured":"Holden SK, Finseth T, Sillau SH, Berman BD (2018) Progression of MDS-UPDRS scores over five years in de novo Parkinson disease from the Parkinson\u2019s progression markers initiative cohort. Mov Disord Clin Pract 5:47\u201353","journal-title":"Mov Disord Clin Pract"},{"key":"12477_CR5","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1002\/mds.22875","volume":"25","author":"YJ Zhao","year":"2010","unstructured":"Zhao YJ, Wee HL, Chan YH, Seah SH, Au WL, Lau PN, Pica EC, Li SC, Luo N, Tan LC (2010) Progression of Parkinson\u2019s disease as evaluated by Hoehn and Yahr stage transition times. Mov Disord 25:710\u2013716","journal-title":"Mov Disord"},{"key":"12477_CR6","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1038\/s41531-018-0069-x","volume":"4","author":"P Eusebi","year":"2018","unstructured":"Eusebi P, Romoli M, Paoletti FP, Tambasco N, Calabresi P, Parnetti L (2018) Risk factors of levodopa-induced dyskinesia in Parkinson\u2019s disease: results from the PPMI cohort. NPJ Parkinsons Dis 4:33","journal-title":"NPJ Parkinsons Dis"},{"key":"12477_CR7","first-page":"e1650","volume":"95","author":"SJ Chung","year":"2020","unstructured":"Chung SJ, Lee HS, Kim HR, Yoo HS, Lee YH, Jung JH, Baik K, Ye BS, Sohn YH, Lee PH (2020) Factor analysis-derived cognitive profile predicting early dementia conversion in PD. Neurology 95:e1650\u2013e1659","journal-title":"Neurology"},{"key":"12477_CR8","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1136\/jnnp-2017-315873","volume":"89","author":"SJ Chung","year":"2018","unstructured":"Chung SJ, Yoo HS, Moon H, Oh JS, Kim JS, Park YH, Hong JY, Ye BS, Sohn YH, Lee PH (2018) Early-onset drug-induced parkinsonism after exposure to offenders implies nigrostriatal dopaminergic dysfunction. J Neurol Neurosurg Psychiatry 89:169\u2013174","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"12477_CR9","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1002\/mds.28510","volume":"36","author":"SH Jeong","year":"2021","unstructured":"Jeong SH, Lee HS, Jung JH, Baik K, Lee YH, Yoo HS, Sohn YH, Chung SJ, Lee PH (2021) White matter hyperintensities, dopamine loss, and motor deficits in de novo Parkinson\u2019s disease. Mov Disord 36:1411\u20131419","journal-title":"Mov Disord"},{"key":"12477_CR10","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1016\/j.parkreldis.2013.03.002","volume":"19","author":"YE Kim","year":"2013","unstructured":"Kim YE, Lee W-w, Yun JY, Yang HJ, Kim H-J, Jeon BS (2013) Musculoskeletal problems in Parkinson\u2019s disease: neglected issues. Parkinsonism Relat Disord 19:666\u2013669","journal-title":"Parkinsonism Relat Disord"},{"key":"12477_CR11","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1002\/mds.25975","volume":"29","author":"J Kraemmer","year":"2014","unstructured":"Kraemmer J, Kovacs GG, Perju-Dumbrava L, Pirker S, Traub-Weidinger T, Pirker W (2014) Correlation of striatal dopamine transporter imaging with post mortem substantia nigra cell counts. Mov Disord 29:1767\u20131773","journal-title":"Mov Disord"},{"key":"12477_CR12","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1002\/ana.22284","volume":"69","author":"R de la Fuente-Fernandez","year":"2011","unstructured":"de la Fuente-Fernandez R, Schulzer M, Kuramoto L, Cragg J, Ramachandiran N, Au WL, Mak E, McKenzie J, McCormick S, Sossi V, Ruth TJ, Lee CS, Calne DB, Stoessl AJ (2011) Age-specific progression of nigrostriatal dysfunction in Parkinson\u2019s disease. Ann Neurol 69:803\u2013810","journal-title":"Ann Neurol"},{"key":"12477_CR13","doi-asserted-by":"crossref","first-page":"349","DOI":"10.3389\/fnins.2020.00349","volume":"14","author":"R Cao","year":"2020","unstructured":"Cao R, Chen X, Xie C, Hu P, Wang K (2020) Serial dopamine transporter imaging of nigrostriatal function in Parkinson\u2019s disease with probable REM sleep behavior disorder. Front Neurosci 14:349","journal-title":"Front Neurosci"},{"key":"12477_CR14","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1002\/mds.26424","volume":"30","author":"RB Postuma","year":"2015","unstructured":"Postuma RB, Berg D, Stern M, Poewe W, Olanow CW, Oertel W, Obeso J, Marek K, Litvan I, Lang AE, Halliday G, Goetz CG, Gasser T, Dubois B, Chan P, Bloem BR, Adler CH, Deuschl G (2015) MDS clinical diagnostic criteria for Parkinson\u2019s disease. Mov Disord 30:1591\u20131601","journal-title":"Mov Disord"},{"key":"12477_CR15","doi-asserted-by":"crossref","first-page":"351","DOI":"10.2214\/ajr.149.2.351","volume":"149","author":"F Fazekas","year":"1987","unstructured":"Fazekas F, Chawluk JB, Alavi A, Hurtig HI, Zimmerman RA (1987) MR signal abnormalities at 1.5 T in Alzheimer\u2019s dementia and normal aging. AJR Am J Roentgenol 149:351\u2013356","journal-title":"AJR Am J Roentgenol"},{"key":"12477_CR16","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1002\/mds.22340","volume":"23","author":"CG Goetz","year":"2008","unstructured":"Goetz CG, Tilley BC, Shaftman SR, Stebbins GT, Fahn S, Martinez-Martin P, Poewe W, Sampaio C, Stern MB, Dodel R, Dubois B, Holloway R, Jankovic J, Kulisevsky J, Lang AE, Lees A, Leurgans S, LeWitt PA, Nyenhuis D, Olanow CW, Rascol O, Schrag A, Teresi JA, van Hilten JJ, LaPelle N (2008) Movement Disorder Society-sponsored revision of the Unified Parkinson\u2019s Disease Rating Scale (MDS-UPDRS): scale presentation and clinimetric testing results. Mov Disord 23:2129\u20132170","journal-title":"Mov Disord"},{"key":"12477_CR17","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1002\/mds.25122","volume":"27","author":"CG Goetz","year":"2012","unstructured":"Goetz CG, Stebbins GT, Tilley BC (2012) Calibration of unified Parkinson\u2019s disease rating scale scores to Movement Disorder Society-unified Parkinson\u2019s disease rating scale scores. Mov Disord 27:1239\u20131242","journal-title":"Mov Disord"},{"key":"12477_CR18","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1002\/acn3.268","volume":"3","author":"V Kaasinen","year":"2016","unstructured":"Kaasinen V (2016) Ipsilateral deficits of dopaminergic neurotransmission in Parkinson\u2019s disease. Ann Clin Transl Neurol 3:21\u201326","journal-title":"Ann Clin Transl Neurol"},{"key":"12477_CR19","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1016\/j.sleep.2011.01.015","volume":"12","author":"T Nomura","year":"2011","unstructured":"Nomura T, Inoue Y, Kagimura T, Uemura Y, Nakashima K (2011) Utility of the REM sleep behavior disorder screening questionnaire (RBDSQ) in Parkinson\u2019s disease patients. Sleep Med 12:711\u2013713","journal-title":"Sleep Med"},{"key":"12477_CR20","doi-asserted-by":"crossref","first-page":"2314","DOI":"10.1002\/mds.21844","volume":"22","author":"B Dubois","year":"2007","unstructured":"Dubois B, Burn D, Goetz C, Aarsland D, Brown RG, Broe GA, Dickson D, Duyckaerts C, Cummings J, Gauthier S, Korczyn A, Lees A, Levy R, Litvan I, Mizuno Y, McKeith IG, Olanow CW, Poewe W, Sampaio C, Tolosa E, Emre M (2007) Diagnostic procedures for Parkinson\u2019s disease dementia: recommendations from the movement disorder society task force. Mov Disord 22:2314\u20132324","journal-title":"Mov Disord"},{"key":"12477_CR21","first-page":"8","volume":"20","author":"SJ Kang","year":"2002","unstructured":"Kang SJ, Choi SH, Lee BH, Kwon JC, Na DL, Han SH, Korean Dementia Research Group (2002) The reliability and validity of the Korean instrumental activities of daily living (K-IADL). J Korean Neurol Assoc 20:8\u201314","journal-title":"J Korean Neurol Assoc"},{"key":"12477_CR22","volume":"10","author":"JS Kim","year":"2015","unstructured":"Kim JS, Cho H, Choi JY, Lee SH, Ryu YH, Lyoo CH, Lee MS (2015) Feasibility of computed tomography-guided methods for spatial normalization of dopamine transporter positron emission tomography image. PLoS ONE 10:e0132585","journal-title":"PLoS ONE"},{"key":"12477_CR23","doi-asserted-by":"crossref","first-page":"399","DOI":"10.2967\/jnumed.111.095224","volume":"53","author":"M Oh","year":"2012","unstructured":"Oh M, Kim JS, Kim JY, Shin KH, Park SH, Kim HO, Moon DH, Oh SJ, Chung SJ, Lee CS (2012) Subregional patterns of preferential striatal dopamine transporter loss differ in Parkinson disease, progressive supranuclear palsy, and multiple-system atrophy. J Nucl Med 53:399\u2013406","journal-title":"J Nucl Med"},{"key":"12477_CR24","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1002\/ana.25103","volume":"82","author":"V Kaasinen","year":"2017","unstructured":"Kaasinen V, Vahlberg T (2017) Striatal dopamine in Parkinson disease: a meta-analysis of imaging studies. Ann Neurol 82:873\u2013882","journal-title":"Ann Neurol"},{"key":"12477_CR25","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0076595","volume":"8","author":"L Kuramoto","year":"2013","unstructured":"Kuramoto L, Cragg J, Nandhagopal R, Mak E, Sossi V, de la Fuente-Fernandez R, Stoessl AJ, Schulzer M (2013) The nature of progression in Parkinson\u2019s disease: an application of non-linear, multivariate, longitudinal random effects modelling. PLoS ONE 8:e76595","journal-title":"PLoS ONE"},{"key":"12477_CR26","first-page":"1694","volume":"45","author":"J Schwarz","year":"2004","unstructured":"Schwarz J, Storch A, Koch W, Pogarell O, Radau PE, Tatsch K (2004) Loss of dopamine transporter binding in Parkinson\u2019s disease follows a single exponential rather than linear decline. J Nucl Med 45:1694\u20131697","journal-title":"J Nucl Med"},{"key":"12477_CR27","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1001\/archneur.62.3.378","volume":"62","author":"R Hilker","year":"2005","unstructured":"Hilker R, Schweitzer K, Coburger S, Ghaemi M, Weisenbach S, Jacobs AH, Rudolf J, Herholz K, Heiss WD (2005) Nonlinear progression of Parkinson disease as determined by serial positron emission tomographic imaging of striatal fluorodopa F 18 activity. Arch Neurol 62:378\u2013382","journal-title":"Arch Neurol"},{"key":"12477_CR28","doi-asserted-by":"crossref","first-page":"1853","DOI":"10.1093\/brain\/awab061","volume":"144","author":"N Van Den Berge","year":"2021","unstructured":"Van Den Berge N, Ferreira N, Mikkelsen TW, Alstrup AKO, Tamg\u00fcney G, Karlsson P, Terkelsen AJ, Nyengaard JR, Jensen PH, Borghammer P (2021) Ageing promotes pathological alpha-synuclein propagation and autonomic dysfunction in wild-type rats. Brain 144:1853\u20131868","journal-title":"Brain"},{"key":"12477_CR29","doi-asserted-by":"crossref","first-page":"501","DOI":"10.3233\/JPD-191683","volume":"9","author":"S Cerri","year":"2019","unstructured":"Cerri S, Mus L, Blandini F (2019) Parkinson\u2019s disease in women and men: what\u2019s the difference? J Parkinsons Dis 9:501\u2013515","journal-title":"J Parkinsons Dis"},{"key":"12477_CR30","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1136\/jnnp.2006.103788","volume":"78","author":"CA Haaxma","year":"2007","unstructured":"Haaxma CA, Bloem BR, Borm GF, Oyen WJ, Leenders KL, Eshuis S, Booij J, Dluzen DE, Horstink MW (2007) Gender differences in Parkinson\u2019s disease. J Neurol Neurosurg Psychiatry 78:819\u2013824","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"12477_CR31","doi-asserted-by":"crossref","first-page":"e48","DOI":"10.1212\/WNL.0000000000004764","volume":"90","author":"N Dahodwala","year":"2018","unstructured":"Dahodwala N, Shah K, He Y, Wu SS, Schmidt P, Cubillos F, Willis AW (2018) Sex disparities in access to caregiving in Parkinson disease. Neurology 90:e48\u2013e54","journal-title":"Neurology"},{"key":"12477_CR32","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2022.105668","volume":"167","author":"C Boccalini","year":"2022","unstructured":"Boccalini C, Carli G, Pilotto A, Padovani A, Perani D (2022) Gender differences in dopaminergic system dysfunction in de novo Parkinson\u2019s disease clinical subtypes. Neurobiol Dis 167:105668","journal-title":"Neurobiol Dis"},{"key":"12477_CR33","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1136\/jnnp-2015-312283","volume":"87","author":"F Moisan","year":"2016","unstructured":"Moisan F, Kab S, Mohamed F, Canonico M, Guern ML, Quintin C, Carcaillon L, Nicolau J, Duport N, Singh-Manoux A, Boussac-Zarebska M, Elbaz A (2016) Parkinson disease male-to-female ratios increase with age: French nationwide study and meta-analysis. J Neurol Neurosurg Psychiatry 87:952\u2013957","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"12477_CR34","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1186\/s12944-020-01284-w","volume":"19","author":"X Fu","year":"2020","unstructured":"Fu X, Wang Y, He X, Li H, Liu H, Zhang X (2020) A systematic review and meta-analysis of serum cholesterol and triglyceride levels in patients with Parkinson\u2019s disease. Lipids Health Dis 19:97","journal-title":"Lipids Health Dis"},{"key":"12477_CR35","volume":"6","author":"X Huang","year":"2011","unstructured":"Huang X, Auinger P, Eberly S, Oakes D, Schwarzschild M, Ascherio A, Mailman R, Chen H (2011) Serum cholesterol and the progression of Parkinson\u2019s disease: results from DATATOP. PLoS ONE 6:e22854","journal-title":"PLoS ONE"},{"key":"12477_CR36","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.parkreldis.2022.02.011","volume":"97","author":"JH Kim","year":"2022","unstructured":"Kim JH, Chang IB, Kim YH, Kwon MJ, Kim JH, Choi HG (2022) Association between statin use and Parkinson\u2019s disease in Korean patients with hyperlipidemia. Parkinsonism Relat Disord 97:15\u201324","journal-title":"Parkinsonism Relat Disord"},{"key":"12477_CR37","doi-asserted-by":"crossref","first-page":"3191","DOI":"10.1093\/brain\/awab292","volume":"144","author":"SH Jeong","year":"2021","unstructured":"Jeong SH, Lee HS, Chung SJ, Yoo HS, Jung JH, Baik K, Lee YH, Sohn YH, Lee PH (2021) Effects of statins on dopamine loss and prognosis in Parkinson\u2019s disease. Brain 144:3191\u20133200","journal-title":"Brain"},{"key":"12477_CR38","volume":"12","author":"R Paul","year":"2017","unstructured":"Paul R, Choudhury A, Kumar S, Giri A, Sandhir R, Borah A (2017) Cholesterol contributes to dopamine-neuronal loss in MPTP mouse model of Parkinson\u2019s disease: involvement of mitochondrial dysfunctions and oxidative stress. PLoS ONE 12:e0171285","journal-title":"PLoS ONE"},{"key":"12477_CR39","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1159\/000496977","volume":"52","author":"J Chen","year":"2019","unstructured":"Chen J, Zhang C, Wu Y, Zhang D (2019) Association between hypertension and the risk of Parkinson\u2019s disease: a meta-analysis of analytical studies. Neuroepidemiology 52:181\u2013192","journal-title":"Neuroepidemiology"},{"key":"12477_CR40","doi-asserted-by":"crossref","first-page":"2614","DOI":"10.2337\/dc11-1584","volume":"34","author":"E Cereda","year":"2011","unstructured":"Cereda E, Barichella M, Pedrolli C, Klersy C, Cassani E, Caccialanza R, Pezzoli G (2011) Diabetes and risk of Parkinson\u2019s disease: a systematic review and meta-analysis. Diabetes Care 34:2614\u20132623","journal-title":"Diabetes Care"},{"key":"12477_CR41","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.3233\/JPD-212725","volume":"11","author":"K Komici","year":"2021","unstructured":"Komici K, Femminella GD, Bencivenga L, Rengo G, Pagano G (2021) Diabetes mellitus and Parkinson\u2019s disease: a systematic review and meta-analyses. J Parkinsons Dis 11:1585\u20131596","journal-title":"J Parkinsons Dis"},{"key":"12477_CR42","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.3233\/JPD-202525","volume":"11","author":"M Cotogni","year":"2021","unstructured":"Cotogni M, Sacchi L, Sadikov A, Georgiev D (2021) Asymmetry at disease onset is not a predictor of Parkinson\u2019s disease progression. J Parkinsons Dis 11:1689\u20131694","journal-title":"J Parkinsons Dis"},{"key":"12477_CR43","doi-asserted-by":"crossref","first-page":"455","DOI":"10.3233\/JPD-202481","volume":"11","author":"P Borghammer","year":"2021","unstructured":"Borghammer P (2021) The \u03b1-synuclein origin and connectome model (SOC Model) of Parkinson\u2019s disease: explaining motor asymmetry, non-motor phenotypes, and cognitive decline. J Parkinsons Dis 11:455\u2013474","journal-title":"J Parkinsons Dis"},{"key":"12477_CR44","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1136\/jnnp.54.5.388","volume":"54","author":"WR Gibb","year":"1991","unstructured":"Gibb WR, Lees AJ (1991) Anatomy, pigmentation, ventral and dorsal subpopulations of the substantia nigra, and differential cell death in Parkinson\u2019s disease. J Neurol Neurosurg Psychiatry 54:388\u2013396","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"12477_CR45","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.parkreldis.2022.08.006","volume":"103","author":"HK Kim","year":"2022","unstructured":"Kim HK, Lee MJ, Yoo HS, Lee JH, Ryu YH, Lyoo CH (2022) Temporal trajectory model for dopaminergic input to the striatal subregions in Parkinson\u2019s disease. Parkinsonism Relat Disord 103:42\u201349","journal-title":"Parkinsonism Relat Disord"},{"key":"12477_CR46","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1007\/s00259-017-3844-8","volume":"45","author":"HS Yoo","year":"2018","unstructured":"Yoo HS, Chung SJ, Chung SJ, Moon H, Oh JS, Kim JS, Hong JY, Ye BS, Sohn YH, Lee PH (2018) Presynaptic dopamine depletion determines the timing of levodopa-induced dyskinesia onset in Parkinson\u2019s disease. Eur J Nucl Med Mol Imaging 45:423\u2013431","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"12477_CR47","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1136\/jnnp-2018-320157","volume":"90","author":"P Jacopo","year":"2019","unstructured":"Jacopo P, Rory D, Louise W, Morten Gersel S, Lynn R, David James B, David B, Nicola P (2019) Clinical implications of early caudate dysfunction in Parkinson\u2019s disease. J Neurol Neurosurg Psychiatry 90:1098","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"12477_CR48","doi-asserted-by":"crossref","first-page":"S52","DOI":"10.1016\/S1353-8020(11)70018-9","volume":"18","author":"KL Double","year":"2012","unstructured":"Double KL (2012) Neuronal vulnerability in Parkinson\u2019s disease. Parkinsonism Relat Disord 18:S52\u2013S54","journal-title":"Parkinsonism Relat Disord"},{"key":"12477_CR49","doi-asserted-by":"crossref","first-page":"2242","DOI":"10.1152\/jn.00270.2012","volume":"108","author":"EY Choi","year":"2012","unstructured":"Choi EY, Yeo BT, Buckner RL (2012) The organization of the human striatum estimated by intrinsic functional connectivity. J Neurophysiol 108:2242\u20132263","journal-title":"J Neurophysiol"},{"key":"12477_CR50","doi-asserted-by":"crossref","first-page":"250","DOI":"10.3390\/genes9050250","volume":"9","author":"M Rango","year":"2018","unstructured":"Rango M, Bresolin N (2018) Brain mitochondria, aging, and Parkinson\u2019s disease. Genes (Basel) 9:250","journal-title":"Genes (Basel)"}],"container-title":["Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-024-12477-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00415-024-12477-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-024-12477-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,12]],"date-time":"2024-08-12T15:14:32Z","timestamp":1723475672000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00415-024-12477-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,5]]},"references-count":50,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2024,8]]}},"alternative-id":["12477"],"URL":"https:\/\/doi.org\/10.1007\/s00415-024-12477-z","relation":{},"ISSN":["0340-5354","1432-1459"],"issn-type":[{"value":"0340-5354","type":"print"},{"value":"1432-1459","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,6,5]]},"assertion":[{"value":"20 December 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 April 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 May 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 June 2024","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}]}}